European Companies Search Engine

EU funding (€8,499,556): Reducing Non-Human Primates in Non-Clinical Safety Assessment: The European Initiative on Minipig and Micropig Models Hor1 Oct 2024 EU Research and Innovation programme "Horizon"

Overview

Text

The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim a. Rhein, Germany.

Creative Commons License The visualizations for "BOEHRINGER INGELHEIM PHARMA GmbH & Co. KG - EU funding (€8,499,556): Reducing Non-Human Primates in Non-Clinical Safety Assessment: The European Initiative on Minipig and Micropig Models" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.